Publication | Closed Access

Determinants for in vivo anti-tumor effects of PEG liposomal doxorubicin: Importance of vascular permeability within tumors

Vascular PermeabilityTumor BiologyVivo Anti-tumor EffectsOncologyAngiogenesisPeg Liposomal DoxorubicinMedicineVascular BiologyTumor TargetingAnti-cancer AgentPharmacologyRadiation OncologyCancer Research